Bexarotene With Narrow-Band UVB for Psoriasis

This study has been completed.
Sponsor:
Collaborator:
Ligand Pharmaceuticals
Information provided by:
Rutgers, The State University of New Jersey
ClinicalTrials.gov Identifier:
NCT00151008
First received: September 6, 2005
Last updated: August 6, 2008
Last verified: August 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: August 2005
  Estimated Primary Completion Date: No date given